May 18, 2022 Michael P. GrayRetention Agreement • August 3rd, 2022 • IMARA Inc. • Pharmaceutical preparations
You are a key member of the senior management team of Imara Inc. (the “Company”). As a result, subject to the terms and conditions of this letter agreement, you will be eligible for the following retention benefits should you remain employed by the Company through the specified milestones set forth herein. This letter agreement shall amend and restate in its entirety that certain letter agreement, dated May 5, 2022 (the “May 5 Agreement”), between you and the Company and the retention benefits provided herein shall replace any such retention benefits provided in the May 5 Agreement.
